Abstract:Background: Proton relative biological effectiveness (RBE) is known to depend on physical factors of the proton beam, such as its linear energy transfer (LET), as well as on cell-line specific biological factors, such as their ability to repair DNA damage. However, in a clinical setting, proton RBE is still considered to have a fixed value of 1.1 despite the existence of several empirical models that can predict proton RBE based on how a cell's survival curve (linear-quadratic model [LQM]) parameters α and β vary with the LET of the proton beam. Part of the hesitation to incorporate variable RBE models in the clinic is due to the great noise in the biological datasets on which these models are trained, often making it unclear which model, if any, provides sufficiently accurate RBE predictions to warrant a departure from RBE = 1.1. Purpose: Here, we introduce a novel model of proton RBE based on how a cell's intrinsic radiosensitivity varies with LET, rather than its LQM parameters. Methods and materials: We performed clonogenic cell survival assays for eight cell lines exposed to 6 MV x-rays and 1.2, 2.6, or 9.9 keV/µm protons, and combined our measurements with published survival data (n = 397 total cell line/LET combinations). We characterized how radiosensitivity metrics of the form DSF% , (the dose required to achieve survival fraction [SF], e.g., D10% ) varied with proton LET, and calculated the Bayesian information criteria associated with different LET-dependent functions to determine which functions best described the underlying trends. This allowed us to construct a six-parameter model that predicts cells' proton survival curves based on the LET dependence of their radiosensitivity, rather than the LET dependence of the LQM parameters themselves. We compared the accuracy of our model to previously established empirical proton RBE models, and implemented our model within a clinical treatment plan evaluation workflow to demonstrate its feasibility in a clinical setting. Results: Our analyses of the trends in the data show that DSF% is linearly correlated between x-rays and protons, regardless of the choice of the survival level (e.g., D10% , D37% , or D50% are similarly correlated), and that the slope and intercept of these correlations vary with proton LET. The model we constructed based on these trends predicts proton RBE within 15%-30% at the 68.3% confidence level and offers a more accurate general description of the experimental data than previously published empirical models. In the context of a clinical treatment plan, our model generally predicted higher RBE-weighted doses than the other empirical models, with RBE-weighted doses in the distal portion of the field being up to 50.7% higher than the planned RBE-weighted doses (RBE = 1.1) to the tumor. Conclusions: We established a new empirical proton RBE model that is more accurate than previous empirical models, and that predicts much higher RBE values in the distal edge of clinical proton beams.

Interpreting the biological effects of protons as a function of physical quantity: linear energy transfer or microdosimetric lineal energy spectrum?

An empirical model of proton RBE based on the linear correlation between x-ray and proton radiosensitivity

LET-weighted doses effectively reduce biological variability in proton radiotherapy planning

Enhanced RBE of Particle Radiation Depends on Beam Size in the Micrometer Range

A Monte Carlo study of different LET definitions and calculation parameters for proton beam therapy

Fitting the Generalized Target Model to Cell Survival Data of Proton Radiation Reveals Dose-Dependent RBE and Inspires an Alternative Method to Estimate RBE in High-Dose Regions

Relative biological effectiveness of clinically relevant photon energies for the survival of human colorectal, cervical, and prostate cancer cell lines

Beyond a constant proton relative biological effectiveness: A survey of clinical and research perspectives among proton institutions in Europe and the United States

Nanodosimetric Understanding to the Dependence of the Relationship Between Dose-Averaged Lineal Energy on Nanoscale and LET on Ion Species.

Exploring the Advantages of Intensity-Modulated Proton Therapy: Experimental Validation of Biological Effects Using Two Different Beam Intensity-Modulation Patterns

Brain-Specific Relative Biological Effectiveness of Protons Based on Long-term Outcome of Patients With Nasopharyngeal Carcinoma

Mechanistic modelling of relative biological effectiveness of carbon ion beams and comparison with experiments

DNA double-strand breaks in cancer cells as a function of proton linear energy transfer and its variation in time

LET‐based approximation of the microdosimetric kinetic model for proton radiotherapy

Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response

Novel radiation quality metrics accounting for proton energy spectra for RBE proton models

Detailed analysis of the cell-inactivation mechanism by accelerated protons and light ions

Linear Energy Transfer Measurements and Estimation of Relative Biological Effectiveness in Proton and Helium-Ion Beams Using Fluorescent Nuclear Track Detectors

Charged Particle Radiobiology Beamline Using Tandem Accelerator-Based MeV Protons and Carbon Ions: a Pilot Study on the Track-End Radiation Quality, Variable Biological Effectiveness and Bayesian Beam Dosimetry

An ion-independent phenomenological relative biological effectiveness (RBE) model for proton therapy

Discussing the discrepancy between analytical calculations and the observed biological effectiveness in proton boron capture therapy (pbct)